Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer

Authors

Xuxu Gou, Baylor College of Medicine
Shunqiang Li, Washington University School of Medicine in St. Louis
et al.

Journal

Cancer Research

Publication Date

10-2-2023

Volume

83

Issue

19

First Page

3237

Last Page

3251

Document Type

Open Access Publication

DOI

10.1158/0008-5472.CAN-22-3484

Rights and Permissions

Gou X, Kim BJ, Anurag M, Lei JT, Young MN, Holt MV, Fandino D, Vollert CT, Singh P, Alzubi MA, Malovannaya A, Dobrolecki LE, Lewis MT, Li S, Foulds CE, Ellis MJ. Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer. Cancer Res. 2023 Oct 2;83(19):3237-3251. doi: 10.1158/0008-5472.CAN-22-3484. ©2023 The Authors; Published by the American Association for Cancer Research This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

Recommended Citation

Gou, Xuxu; Li, Shunqiang; and et al., "Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer." Cancer Research. 83, 19. 3237 - 3251. (2023).
https://digitalcommons.wustl.edu/oa_4/3150

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.